Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5851)
All Articles published online
|
Publishing Process of This Article
|
Jul 26, 2013 (publication date) through Jul 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Khan MA, Ahmed F, Neyses L, Mamas MA. Atrial fibrillation in heart failure: The sword of Damocles revisited. World J Cardiol 2013; 5(7): 215-227 [PMID: 23888191 DOI: 10.4330/wjc.v5.i7.215] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v5/i7/215.htm |
| Number | Citing Articles |
| 1 |
Muhammad A Khan, Duwarakan K Satchithananda, Mamas A Mamas. The importance of interactions between atrial fibrillation and heart failure. Clinical Medicine 2016; 16(3): 272 doi: 10.7861/clinmedicine.16-3-272
|
| 2 |
Jeffrey S. Berger, Eric Peterson, François LalibertÉ, Guillaume Germain, Dominique Lejeune, Jeff Schein, Patrick Lefebvre, Qi Zhao, Matthew R. Weir. Risk of Ischemic Stroke in Patients Newly Diagnosed With Heart Failure: Focus on Patients Without Atrial Fibrillation. Journal of Cardiac Failure 2019; 25(6): 436 doi: 10.1016/j.cardfail.2018.03.012
|
| 3 |
Ayodele Odutayo, Christopher X. Wong, Rashida Williams, Benjamin Hunn, Connor A. Emdin. Prognostic Importance of Atrial Fibrillation Timing and Pattern in Adults With Congestive Heart Failure: A Systematic Review and Meta-Analysis. Journal of Cardiac Failure 2017; 23(1): 56 doi: 10.1016/j.cardfail.2016.08.005
|
| 4 |
Wan-Li Cheng, Yu-Hsun Kao, Shih-Ann Chen, Yi-Jen Chen. Pathophysiology of cancer therapy-provoked atrial fibrillation. International Journal of Cardiology 2016; 219: 186 doi: 10.1016/j.ijcard.2016.06.009
|
| 5 |
Yen Yen Ari Indrawijaya, Suharjono Suharjono, Muhammad Aminuddin, Endang Retnowati, Gilang Mauladi Rahman. Changes on Serum Troponin T Level before and after Taking Standard Therapy Medication in Heart Failure Patients. Folia Medica Indonesiana 2021; 56(1): 4 doi: 10.20473/fmi.v56i1.24548
|
| 6 |
Xinyu Yang, Xinye Li, Mengchen Yuan, Chao Tian, Yihan Yang, Xiaofeng Wang, Xiaoyu Zhang, Yang Sun, Tianmai He, Songjie Han, Guang Chen, Nian Liu, Yonghong Gao, Dan Hu, Yanwei Xing, Hongcai Shang. Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01058
|
| 7 |
Luigi Di Biase, Prasant Mohanty, Sanghamitra Mohanty, Pasquale Santangeli, Chintan Trivedi, Dhanunjaya Lakkireddy, Madhu Reddy, Pierre Jais, Sakis Themistoclakis, Antonio Dello Russo, Michela Casella, Gemma Pelargonio, Maria Lucia Narducci, Robert Schweikert, Petr Neuzil, Javier Sanchez, Rodney Horton, Salwa Beheiry, Richard Hongo, Steven Hao, Antonio Rossillo, Giovanni Forleo, Claudio Tondo, J. David Burkhardt, Michel Haissaguerre, Andrea Natale. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device. Circulation 2016; 133(17): 1637 doi: 10.1161/CIRCULATIONAHA.115.019406
|
| 8 |
Maria Cristina Vedovati, Michela Giustozzi, Paolo Verdecchia, Lucia Pierpaoli, Serenella Conti, Melina Verso, Francesco Di Filippo, Emanuela Marchesini, Giulio Bogliari, Giancarlo Agnelli, Cecilia Becattini. Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study. International Journal of Cardiology 2018; 269: 152 doi: 10.1016/j.ijcard.2018.07.138
|
| 9 |
Yu. A. Vasyuk, E. Yu. Shupenina, D. A. Vyzhigin, E. O. Novosel, K. V. Gallinger. Atrial Fibrillation in Cancer Patients: Who is at Risk?. Rational Pharmacotherapy in Cardiology 2022; 17(6): 900 doi: 10.20996/1819-6446-2021-12-03
|
| 10 |
V. Katsi, G. Georgiopoulos, A. Laina, E. Koutli, J. Parissis, C. Tsioufis, P. Nihoyannopoulos, D. Tousoulis. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?. Heart Failure Reviews 2017; 22(6): 641 doi: 10.1007/s10741-017-9624-5
|
| 11 |
I. R. Rakhimova, T. N. Khaibullin, V. V. Kovalchuk, A. S. Abdrakhmanov. Atrial fibrillation and stroke risk factors in patients with cardiac implantable electronic devices. Journal of Arrhythmology 2021; 28(3): 28 doi: 10.35336/VA-2021-3-28-36
|
| 12 |
Peter Marschang. NOAK bei Herzinsuffizienz. Wiener klinisches Magazin 2014; 17(6): 4 doi: 10.1007/s00740-014-0003-8
|
| 13 |
Jan M. Van Keer, Thomas Vanassche, Walter Droogne, Steffen Rex, Filip Rega, Johan Van Cleemput, Peter Verhamme. Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation. European Journal of Heart Failure 2019; 21(1): 129 doi: 10.1002/ejhf.1356
|
| 14 |
Osmar Antonio Centurion. The Influence of Atrial Fibrillation on Cardiac Resynchronization Therapy. Journal of Cardiology & Current Research 2014; 1(2) doi: 10.15406/jccr.2014.01.00008
|